Snapshot

The The time-limited conditional approval system for regenerative medicines pathway has been developed by the  Pharmaceuticals and Medical Devices Agency of Japan.

This pathway accelerates the regulatory review process.

It is an abridged review (a reliance pathway).

Target time assessment is Info not found.